← Human Trials & Peer-Reviewed Studies
The effect of vitamin D and calcium supplementation on inflammatory biomarkers, estradiol levels and severity of symptoms in women with postpartum depression: a randomized double-blind clinical trial.
Plain-language guide to PMID 31900080 (2022): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 27 patients.
Key Facts
- PMID
- 31900080
- Journal
- Nutritional neuroscience
- Year
- 2022
- Study type
- Randomized Controlled Trial
- Authors
- Amini S et al. (6 authors)
- DOI
- 10.1080/1028415X.2019.1707396
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
This study was designed to determine the effect of vitamin D and calcium supplementation on the severity of symptoms and some related inflammatory biomarkers in women with PPD.Materials and Methods: Eighty-one women with a PPD score >12 participated in this study.
Why It Was Studied
Objectives: Postpartum depression (PPD) is a major depressive disorder.
Vitamin D deficiency may play a role in PPD pathogenesis.
Who Took Part
The study group was 27 patients.
PubMed tags the participants as women only.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Blinding on both sides kept the patients and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
Some patients received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
What Was Measured
The subject headings attached to it are Biomarkers, Calcium, Depression, Postpartum, Dietary Supplements, Estradiol, Inflammation and Interleukin-6.
Author keywords: Vitamin D, high sensitive C-reactive protein, inflammatory mediators, interleukin 6 and tumor necrosis factor-alpha.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 27 patients.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2022 (Nutritional neuroscience), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.